Conversely, mTOR inhibitors in hepatocellular carcinoma decrease global O‐GlcNAcylation by promoting OGT degradation via ubiquitin–proteasome and selective autophagy pathways, establishing a negative feedback loop.61 The gene discussed is OGT; the disease is hepatocellular carcinoma.